Corrigendum to: Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients with Crohn Disease: Posthoc Analysis of the LOVE-CD Study

por Hanzel, Jurij, Dreesen, Erwin, Vermeire, Séverine, Löwenberg, Mark, Hoentjen, Frank, Bossuyt, Peter, Clasquin, Esmé, Baert, Filip J, D’Haens, Geert R, Mathôt, Ron
Publicado 2021

Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients With Crohn Disease: Posthoc Analysis of the LOVE-CD Study

por Hanzel, Jurij, Dreesen, Erwin, Vermeire, Séverine, Löwenberg, Mark, Hoentjen, Frank, Bossuyt, Peter, Clasquin, Esmé, Baert, Filip J, D’Haens, Geert R, Mathôt, Ron
Publicado 2021

Su1501: PROPHYLACTIC VERSUS ENDOSCOPY DRIVEN TREATMENT OF CROHN'S POSTOPERATIVE RECURRENCE: A RETROSPECTIVE MULTICENTRIC EUROPEAN STUDY

por Geldof, Jeroen, Truyens, Marie, Hanssens, Michiel, Holvoet, Tom, Ainara, Elorza, Bouillon, Vincent, Barros, Sónia, Argyriou, Konstantinos, Diculescu, Mircea, Moens, Annick, Theodoraki, Eirini, Serrazina, Juliana, Nikolaou, Pinelopi, Baert, Filip J., Ferreiro, Rocio, Peeters, Harald, Casanova, Mariá José, Eder, Piotr, Porter, Ross J., Karakan, Tarkan, Mesonero, Francisco, Revés, Joana, Evi, Van Dyck, Jauregui-Amezaga, Aranzazu, Mañosa, Miriam, Rivière, Pauline, Mosquera, Lucia Marquez, Portela, Francisco, Lobaton, Triana
Publicado 2022